Starboard CEO Jeff Smith Says Return On Invested Capital In Pfizer Is Not Working; Says "Growth They're Producing From Their Investments Is Worst In Class"; Its A Great American Company
Portfolio Pulse from Benzinga Newsdesk
Starboard CEO Jeff Smith criticizes Pfizer's return on invested capital, stating that the growth from their investments is 'worst in class'. Despite this, he acknowledges Pfizer as a great American company.
October 22, 2024 | 1:48 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Starboard CEO Jeff Smith criticizes Pfizer's return on invested capital, labeling their growth from investments as 'worst in class'. This negative assessment could impact investor sentiment.
The CEO of Starboard, a notable investment firm, publicly criticized Pfizer's return on invested capital, which could lead to negative investor sentiment and potential short-term stock price decline.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90